Anteris Technologies Global Corp.’s AVR share price has dipped by 7.04%, which has investors questioning if this is right ...

Anteris Technologies Global Corp.’s AVR share price has surged by 12.25%, which has investors questioning if this is right time to sell.

In both patient- and cell-line derived xenograft (PDX and CDX ... and operating under the brand name "Amber Premium", today announced that it filed... 29 avr 2025 TOTAL PLAY ANNOUNCES REVENUE OF Ps.10 ...

Ensem Therapeutics, Inc. (ENSEM) today announced the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for ETX-636, a potential best-in-class ...

In the study, pH-dependent binding of MYTX-011 translated to potent efficacy in tumor xenografts regardless of mutation status, including models harboring MET exon 14 skipping, KRAS and EGFR ...

These results demonstrate that the axis of interleukin 12 and gamma interferon provides a survival advantage in vascularized xenografts by delaying or preventing acute vascular rejection caused by ...

In addition, the team early on successfully reversed an episode of acute rejection in that baboon, the first time that’s been done for a xenograft. That work was recently published in ...

The in vivo anti-lymphoma efficacy and pharmacodynamic effect were evaluated in Raji xenograft model. The tissue resident B cell depletion was assessed in CD34+ hematopoietic stem cells humanized mice ...

At close: 3:01:57 PM GMT+10 ...